Search for Clinical Trial Results
Giant Cell Arteritis - 26 Studies Found
Status | Study |
Recruiting |
Study Name: Study of Phenotypic and Functional Characteristics of Regulatory T Lymphocytes in Horton's Disease Condition: Horton's Disease Date: 2016-06-29 Interventions: Biological: Blood samples |
Completed |
Study Name: Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis Condition:
Date: 2007-11-09 Interventions:
|
Recruiting |
Study Name: Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE Condition: Polymyalgia Rheumatica Date: 2016-09-16 Interventions:
|
Completed |
Study Name: Tocilizumab Effect iN pOlymyalgia Rheumatica Condition: Polymyalgia Rheumatica Date: 2012-09-17 Interventions: Drug: TCZ Tocilizumab at week 0, 4 and 8. |
Not yet recruiting |
Study Name: Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia Rheumatica Condition: Polymyalgia Rheumatica Date: 2016-09-08 Interventions:
|
RECRUITING |
Study Name: Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement Condition: Giant Cell Arteritis Date: 2024-05-19 Interventions: Tocilizumab will be administered subcutaneously at a dose of 162mg/0.9mLweekly (each week, on the same day) from week 0 to week 24. |